[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0114873A - Imidazopiridinas polissubstituìdas - Google Patents

Imidazopiridinas polissubstituìdas

Info

Publication number
BR0114873A
BR0114873A BR0114873-7A BR0114873A BR0114873A BR 0114873 A BR0114873 A BR 0114873A BR 0114873 A BR0114873 A BR 0114873A BR 0114873 A BR0114873 A BR 0114873A
Authority
BR
Brazil
Prior art keywords
imidazopyridines
polysubstituted
polysubstituted imidazopyridines
substituents
compounds
Prior art date
Application number
BR0114873-7A
Other languages
English (en)
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BR0114873A publication Critical patent/BR0114873A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"IMIDAZOPIRIDINAS POLISSUBSTITUìDAS". A presente invenção refere-se a imidazopiridinas de uma certa fórmula 1, na qual os substituintes e símbolos têm os significados indicados na descrição. Os compostos têm propriedades inibidoras de secreção gástrica.
BR0114873-7A 2000-10-25 2001-10-23 Imidazopiridinas polissubstituìdas BR0114873A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00123133 2000-10-25
PCT/EP2001/012207 WO2002034749A1 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors

Publications (1)

Publication Number Publication Date
BR0114873A true BR0114873A (pt) 2003-07-01

Family

ID=8170193

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114873-7A BR0114873A (pt) 2000-10-25 2001-10-23 Imidazopiridinas polissubstituìdas

Country Status (19)

Country Link
US (2) US6869949B2 (pt)
EP (1) EP1332143A1 (pt)
JP (1) JP2004512338A (pt)
KR (1) KR20040011423A (pt)
CN (1) CN1692113A (pt)
AU (2) AU1056302A (pt)
BR (1) BR0114873A (pt)
CA (1) CA2426616A1 (pt)
EA (1) EA008151B1 (pt)
HR (1) HRP20030323A2 (pt)
HU (1) HUP0302308A2 (pt)
IL (1) IL154850A0 (pt)
MX (1) MXPA03003706A (pt)
NO (1) NO325736B1 (pt)
NZ (1) NZ525281A (pt)
PL (1) PL360412A1 (pt)
SK (1) SK5072003A3 (pt)
WO (1) WO2002034749A1 (pt)
ZA (1) ZA200302038B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ ファルマ アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
EP1476445A1 (en) 2002-02-15 2004-11-17 ALTANA Pharma AG Tricyclic n-acyl compounds
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines
EA010107B1 (ru) * 2002-12-20 2008-06-30 Алтана Фарма Аг Силиловые простые эфиры
JP2006517952A (ja) * 2003-02-17 2006-08-03 アルタナ ファルマ アクチエンゲゼルシャフト 新規の組合せ物及び選択された医薬有効化合物の新規の使用
CA2520288A1 (en) * 2003-04-03 2004-10-14 Altana Pharma Ag Process for the production of imidazopyridin-8-ones
AR044129A1 (es) 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
AR046941A1 (es) * 2003-12-19 2006-01-04 Altana Pharma Ag Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
EP1797089A1 (en) * 2004-10-01 2007-06-20 Altana Pharma AG Substituted tricyclic benzimidazoles
AR051375A1 (es) * 2004-10-15 2007-01-10 Altana Pharma Ag Imidazopiridinas difluoro substituidas
WO2008058990A1 (en) * 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
CA2102116A1 (en) * 1991-05-31 1992-12-01 Gary R. Schulte Use of rapamycin prodrugs as immunosuppressant agents
DE4308095A1 (de) * 1993-03-13 1994-09-15 Hoechst Ag Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
SE9401197D0 (sv) 1994-04-11 1994-04-11 Astra Ab Active compounds
ATE265455T1 (de) * 1997-03-24 2004-05-15 Altana Pharma Ag Tetrahydropyridoverbindungen
ZA982445B (en) * 1997-03-24 1998-09-24 Byk Gulden Lomberg Chem Fab Tetrahydropyrido compounds
US6160119A (en) * 1997-05-28 2000-12-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
RS50145B (sr) 1998-09-23 2009-03-25 Altana Pharma Ag., Tetrahidropiridoetri
JP2002528548A (ja) * 1998-11-03 2002-09-03 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング イミダゾナフチリジン
EP1173439B1 (en) * 1999-04-17 2003-05-21 ALTANA Pharma AG Haloalkoxy imidazonaphthyridines
ES2267737T3 (es) * 2000-03-29 2007-03-16 Altana Pharma Ag Derivados de imidazopiridinas alquiladas.
ATE356131T1 (de) 2000-03-29 2007-03-15 Altana Pharma Ag Tricyclische imidazopyridine
PL365824A1 (en) 2000-03-29 2005-01-10 Altana Pharma Ag Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
MXPA02009551A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ ファルマ アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン

Also Published As

Publication number Publication date
NO20031830L (no) 2003-04-24
ZA200302038B (en) 2004-04-22
AU1056302A (en) 2002-05-06
PL360412A1 (en) 2004-09-06
EA200300478A1 (ru) 2003-12-25
CA2426616A1 (en) 2002-05-02
KR20040011423A (ko) 2004-02-05
CN1692113A (zh) 2005-11-02
US7141567B2 (en) 2006-11-28
AU2002210563B2 (en) 2007-03-01
EA008151B1 (ru) 2007-04-27
US20040106642A1 (en) 2004-06-03
WO2002034749A1 (en) 2002-05-02
SK5072003A3 (en) 2003-09-11
NZ525281A (en) 2004-11-26
MXPA03003706A (es) 2005-01-25
US20040214852A1 (en) 2004-10-28
HRP20030323A2 (hr) 2005-04-30
NO20031830D0 (no) 2003-04-24
JP2004512338A (ja) 2004-04-22
EP1332143A1 (en) 2003-08-06
NO325736B1 (no) 2008-07-14
US6869949B2 (en) 2005-03-22
HUP0302308A2 (hu) 2003-11-28
IL154850A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
BR0114873A (pt) Imidazopiridinas polissubstituìdas
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
CY1108091T1 (el) Βιολογικως ενεργα παραγωγα μπλε του μεθυλενιου
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
EP1466898A4 (en) INHIBITORS OF THE PRODUCTION / SEPARATION OF BETA-AMYLOIDS PROTEINS
CY1108808T1 (el) Ενωσεις μοτιλιδης
BR0013110A (pt) Forma oral de administração contendo microorganismos probióticos
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
BR0211826A (pt) Imidazopiridinas tricìclicas
EA200200875A1 (ru) Пролекарства производных имидазопиридина
TR200201613T2 (tr) Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler
BRPI0408893A (pt) benzimidazóis cìclicos
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
SE9903290D0 (sv) Novel compounds
BR0316201A (pt) Imidazopiridinas 8-substituìdas
BRPI0416678A (pt) pirazolpirimidinas
BR0309462A (pt) Imidazopiridinas nitrosadas
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
TW200504068A (en) 6-substituted imidazopyrazines
PL345966A1 (en) N-substituted azabicycloheptane derivatives, production and use thereof
BR0000184A (pt) Processo para a preparação de compostos heterocìclicos
BR0211620A (pt) Imidazopiridinas substituìdas por alquila para o tratamento de distúrbios gastrointestinais
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A 2A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2077 DE 26/10/2010.